Introduction {#H1-1-ZOI190594}
============

Medicare beneficiaries who qualify for Medicare because of disability constitute a growing population of patients hospitalized for opioid or heroin overdose^[@zoi190594r1],[@zoi190594r2]^ and account for 25% of deaths from prescription opioid overdose annually.^[@zoi190594r3]^ The Centers for Disease Control and Prevention (CDC) regularly generates reports of opioid overdose deaths by demographic variables and states, but studies on policy-actionable risk factors (eg, clusters of medical and psychiatric conditions or types of disabling conditions) for overdose mortality are lacking in this population.

Methods {#H1-2-ZOI190594}
=======

The University of Texas Medical Branch institutional review board approved this study and waived any informed consent requirement because the research used deidentified data. This study follows the Strengthening the Reporting of Observational Studies in Epidemiology ([STROBE](http://www.equator-network.org/reporting-guidelines/strobe/)) reporting guideline.^[@zoi190594r4]^

Our initial cohort was a 20% national sample of all Medicare enrollees aged 21 to 100 years residing in 50 US states and Washington, DC, in 2012 to 2016. Centers for Medicare & Medicaid Services (CMS) selects a random sample of 20% Medicare beneficiaries according to the last 2 digits of their health insurance claim number. Studies based on these data should provide generalizable estimates for the Medicare population.^[@zoi190594r5]^ We used Medicare summary files linked to the National Death Index. From the National Death Index, we identified drug overdose deaths according to *International Statistical Classification of Diseases and Related Health Problems*,*Tenth Revision*, codes for cause of death: X40-44, X60-64, X85, or Y10-Y14. Opioid overdose deaths were identified by codes T40.0 (opium), T40.1 (heroin), T40.2 (natural or semisynthetic opioids), T40.3 (methadone), T40.4 (synthetic opioids other than methadone), or T40.6 (other and unspecified narcotics) from the underlying conditions.

Patient characteristics included age, sex, race/ethnicity, years under Medicare disability entitlement, health maintenance organization enrollment, and Medicare Part D enrollment for at least 1 month in a year. Race/ethnicity is based on Social Security Administration data, with a surname algorithm enhancing the identification of Hispanic and Asian origin.^[@zoi190594r6]^ Medicaid enrollment was used to represent low income. Education and household income were obtained from the 2011 to 2015 American Community Survey by zip code linkage and were divided into quartiles. Residential area was classified using rural-urban continuum codes.^[@zoi190594r7]^

The CMS Chronic Conditions Data Warehouse listed 27 chronic conditions and 36 potentially disabling conditions as of March 2019. Chronic Conditions Data Warehouse is a research database designed to improve the quality of care and reduce costs and utilization. The specific definition and reference for each condition are available at the Chronic Conditions Data Warehouse website.^[@zoi190594r8]^ We combined these 2 sets of conditions, removed the duplicate conditions (eg, depression and depressive disorder), and consolidated the cancer diagnoses (breast, lung, colorectal, endometrial, prostate cancer, or leukemia and lymphomas). This resulted in 55 chronic or potentially disabling conditions for our study ([Table 1](#zoi190594t1){ref-type="table"}).

###### Comparison of Demographic Characteristics and Medical Conditions Between All Medicare Enrollees Aged 21 to 64 Years Qualified for Disability in 2016 and Those Who Died of Opioid Overdose

  Variables                                                                               Participants, No. (%)   *P* Value[^a^](#zoi190594t1n1){ref-type="table-fn"}   
  --------------------------------------------------------------------------------------- ----------------------- ----------------------------------------------------- --------
  Demographic characteristics                                                                                                                                           
  Age, y                                                                                                                                                                
  21-30                                                                                   84 470 (4.8)            53 (3.9)                                              \<.001
  31-40                                                                                   186 323 (10.6)          234 (17.1)                                            
  41-50                                                                                   328 539 (18.6)          328 (23.9)                                            
  51-64                                                                                   1 167 458 (66.1)        756 (55.1)                                            
  Mean (SD)                                                                               52.2 (10.2)             49.7 (9.9)                                            
  Sex                                                                                                                                                                   
  Male                                                                                    899 876 (50.9)          773 (56.4)                                            .004
  Female                                                                                  866 914 (49.1)          598 (43.6)                                            
  Race/ethnicity                                                                                                                                                        
  White                                                                                   1 170 832 (66.3)        1114 (81.3)                                           \<.001
  Black                                                                                   350 744 (19.9)          127 (9.3)                                             
  Hispanic                                                                                172 862 (9.8)           76 (5.5)                                              
  Other                                                                                   72 352 (4.1)            54 (3.9)                                              
  Years under disability insurance                                                                                                                                      
  ≤4                                                                                      524 930 (29.7)          366 (26.7)                                            \<.001
  5-8                                                                                     509 017 (28.8)          494 (36.0)                                            
  9-14                                                                                    310 789 (17.8)          282 (20.6)                                            
  ≥15                                                                                     422 954 (23.9)          229 (16.7)                                            
  Mean (SD)                                                                               10.2 (8.4)              9.0 (6.4)                                             
  Dual eligible                                                                                                                                                         
  Yes                                                                                     866 544 (49.0)          796 (58.1)                                            \<.001
  No                                                                                      900 246 (51.0)          575 (41.9)                                            
  Zip code education[^b^](#zoi190594t1n2){ref-type="table-fn"}                                                                                                          
  Quartile 1 (lowest)                                                                     577 915 (33.1)          362 (26.7)                                            \<.001
  Quartile 2                                                                              524 919 (30.1)          442 (32.6)                                            
  Quartile 3                                                                              379 445 (21.7)          322 (23.7)                                            
  Quartile 4 (highest)                                                                    263 807 (15.1)          230 (17.0)                                            
  Zip code income[^b^](#zoi190594t1n2){ref-type="table-fn"}                                                                                                             
  Quartile 1 (lowest)                                                                     612 138 (34.8)          432 (31.6)                                            .02
  Quartile 2                                                                              488 192 (27.7)          355 (25.9)                                            
  Quartile 3                                                                              391 224 (22.2)          323 (23.6)                                            
  Quartile 4 (highest)                                                                    268 458 (15.3)          259 (18.9)                                            
  Rural vs urban[^b^](#zoi190594t1n2){ref-type="table-fn"}                                                                                                              
  Metropolitan area                                                                       1 403 542 (79.5)        1178 (85.9)                                           \<.001
  Urban                                                                                   324 070 (18.4)          170 (12.4)                                            
  Rural                                                                                   37 899 (2.1)            23 (1.7)                                              
  HMO enrollment                                                                                                                                                        
  Yes                                                                                     509 657 (28.8)          338 (24.6)                                            .04
  No                                                                                      1 257 133 (71.2)        1033 (75.4)                                           
  Medicare Part D enrollment                                                                                                                                            
  Yes                                                                                     1 412 948 (80.0)        1205 (87.9)                                           \<.001
  No                                                                                      353 842 (20.0)          166 (12.1)                                            
  Medical condition diagnoses[^c^](#zoi190594t1n3){ref-type="table-fn"}                                                                                                 
  Psychiatric diseases                                                                                                                                                  
  Depression                                                                              264 809 (30.2)          436 (56.8)                                            \<.001
  Anxiety                                                                                 279 297 (30.9)          487 (63.4)                                            \<.001
  Bipolar disorder                                                                        122 830 (14.0)          273 (35.6)                                            \<.001
  Schizophrenia and other psychotic disorders                                             100 784 (11.5)          144 (18.8)                                            \<.001
  Attention-deficit/hyperactivity disorder                                                39 812 (4.6)            92 (12.0)                                             \<.001
  Autism                                                                                  12 218 (1.4)            NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Personality disorders                                                                   35 766 (4.1)            75 (9.8)                                              \<.001
  Posttraumatic stress disorder                                                           44 306 (5.1)            94 (12.2)                                             \<.001
  Development disorder                                                                                                                                                  
  Intellectual disabilities                                                               54 008 (6.2)            NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Learning disability                                                                     5112 (0.6)              NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Other developmental delays                                                              6322 (0.7)              NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Cystic fibrosis and other metabolic developmental disorders                             9077 (1.0)              13 (1.7)                                              \>.99
  Substance abuse                                                                                                                                                       
  Tobacco use disorder                                                                    207 378 (23.7)          437 (56.9)                                            \<.001
  Alcohol use disorder                                                                    58 582 (6.7)            186 (24.2)                                            \<.001
  Drug use disorder                                                                       105 625 (12.1)          432 (56.3)                                            \<.001
  Any OUD[^e^](#zoi190594t1n5){ref-type="table-fn"}                                       63 307 (7.2)            389 (50.7)                                            \<.001
  OUD diagnosis or procedure                                                              54 441 (6.2)            351 (45.7)                                            \<.001
  OUD emergency department or hospitalization[^e^](#zoi190594t1n5){ref-type="table-fn"}   30 605 (3.5)            315 (41.0)                                            \<.001
  Use of medication-assisted treatment[^e^](#zoi190594t1n5){ref-type="table-fn"}          11 624 (1.3)            82 (10.7)                                             \<.001
  Disability-related conditions                                                                                                                                         
  Cerebral palsy                                                                          17 024 (1.9)            NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Epilepsy                                                                                69 847 (8.0)            86 (11.2)                                             .07
  Deafness and hearing impairment                                                         25 825 (3.0)            11 (1.4)                                              .59
  Mobility impairment                                                                     38 764 (4.4)            38 (5.0)                                              \>.99
  Multiple sclerosis and transverse myelitis                                              17 747 (2.0)            NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Muscular dystrophy                                                                      2243 (0.3)              NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Spina bifida and other congenital anomalies of the nervous system                       5364 (0.6)              NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Spinal cord injury                                                                      7068 (0.8)              12 (1.6)                                              .73
  Blindness and visual impairment                                                         7919 (0.9)              NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Traumatic brain injury                                                                  8248 (0.9)              NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Pain diagnosis                                                                                                                                                        
  Migraine and other chronic headache                                                     65 303 (7.5)            98 (12.8)                                             \<.001
  Fibromyalgia, chronic pain, and fatigue                                                 271 913 (31.1)          489 (63.7)                                            \<.001
  Chronic conditions                                                                                                                                                    
  Hypertension                                                                            368 959 (42.1)          281 (36.6)                                            .12
  Heart failure                                                                           82 239 (9.4)            90 (11.7)                                             .85
  Ischemic heart disease                                                                  145 398 (16.6)          150 (19.5)                                            .87
  Acute myocardial infarction                                                             5270 (0.6)              NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Atrial fibrillation                                                                     18 905 (2.2)            11 (1.4)                                              \>.99
  Hyperlipidemia                                                                          276 283 (31.6)          136 (17.7)                                            \<.001
  Peripheral vascular disease                                                             65 341 (7.5)            44 (5.7)                                              \>.99
  Stroke                                                                                  22 659 (2.6)            27 (3.5)                                              \>.99
  Arthritis                                                                               250 922 (28.7)          297 (38.7)                                            \<.001
  Asthma                                                                                  73 603 (8.4)            75 (9.8)                                              \>.99
  Cancer                                                                                  34 758 (4.0)            16 (2.1)                                              .40
  Benign prostatic hyperplasia                                                            23 466 (2.7)            15 (2.0)                                              \>.99
  Chronic kidney disease                                                                  156 158 (17.8)          190 (24.7)                                            \<.001
  Chronic obstructive pulmonary disease                                                   112 848 (12.9)          133 (17.3)                                            .02
  Dementia[^f^](#zoi190594t1n6){ref-type="table-fn"}                                      34 062 (4.4)            28 (4.2)                                              \>.99
  Diabetes                                                                                231 423 (26.4)          186 (24.2)                                            \>.99
  Obesity                                                                                 210 268 (24.0)          177 (23.1)                                            \>.99
  Anemia                                                                                  156 457 (17.9)          143 (18.6)                                            \>.99
  Hypothyroidism                                                                          100 638 (11.5)          57 (7.4)                                              .03
  Cataract                                                                                54 849 (6.3)            16 (2.1)                                              \<.001
  Glaucoma                                                                                25 932 (3.0)            NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Osteoporosis                                                                            22 700 (2.6)            13 (1.7)                                              \>.99
  Hip or pelvic fracture                                                                  1887 (0.2)              NA[^d^](#zoi190594t1n4){ref-type="table-fn"}          
  Pressure and chronic ulcers                                                             39 560 (4.5)            61 (7.9)                                              \<.001
  Liver diseases                                                                          55 939 (6.4)            105 (13.7)                                            \<.001
  Hepatitis                                                                               33 977 (3.9)            133 (17.3)                                            \<.001
  HIV                                                                                     15 439 (1.8)            19 (2.5)                                              \>.99

Abbreviations: HMO, health maintenance organization; NA, not applicable; OUD, opioid use disorder.

*P* value from goodness-of-fit test with Bonferroni correction for multiple comparisons. *P* values shown have been calculated by using the following formula: 1 -- (1 -- original *P* value)^57^. There are a total of 68 comparisons in this table.

Variables had missing data.

Data for medical conditions are shown only for 875 682 Medicare recipients who qualified for disability, had 2 years of continuous enrollment in Medicare Part A and B, and were not members of HMOs in 2015 and 2016; 768 died from opioid overdose.

Thirteen conditions associated with fewer than 11 deaths from opioid overdose were not included because of the CMS cell size suppression policy to protect the confidentiality of enrollees.

Not the condition in the Chronic Conditions Data Warehouse. Only for descriptive statistics.

Required 3 years of continuous enrollment in Medicare Part A and B without HMO coverage.

Statistical Analysis {#H2-1-ZOI190594}
--------------------

We calculated the number of deaths from opioid overdose among all Medicare recipients aged 21 to 100 years and the percentage of opioid overdose deaths by age and by reason for initial entitlement (age, disability, or end-stage renal disease) in 2016. Confidence intervals of these percentages were calculated according to multinomial distribution.^[@zoi190594r9]^ Our main analyses focused on enrollees aged 21 to 64 years who initially qualified for Medicare because of disability. We first calculated the rate of opioid overdose deaths from 2012 to 216. Then we restricted the analyses to the 2016 data to compare their characteristics with those who died from opioid overdose, in bivariate analyses using goodness-of-fit test, and reported *P* values with Bonferroni correction for the multiple comparisons. For multivariable analyses, only those with Medicare Part A and B continuous enrollment and without health maintenance organization coverage in 2015 and 2016 were included and analyzed, by a stepwise logistic regression model, to identify conditions and characteristics associated with opioid overdose deaths. Thirteen conditions associated with fewer than 11 deaths from opioid overdose were not included because of the CMS cell size suppression policy to protect the confidentiality of enrollees. No obvious multicollinearity was found, with all correlations among characteristics and study conditions being less than 0.38. On the basis of the results of stepwise logistic regression, we grouped the conditions that were positively associated with opioid overdose death into 3 major common categories of conditions: substance abuse, psychiatric disease, and chronic pain. We analyzed the overlap across these 3 categories to show the proportion of enrollees and opioid overdose mortality for their combinations. The 95% CI of opioid overdose mortality was calculated assuming a Poisson distribution. In addition, we repeated analyses using the 2012 to 2015 data for 2 purposes: to validate our final model in the 2016 data and to expand the conditions associated with fewer than 11 deaths in the 2016 analyses. To compare our results with the CDC report, we calculated age-adjusted rates using the direct method and the 2000 US standard population aged 20 to 64 years. All tests of statistical significance were 2-sided with significance set at *P* \< .05. Analyses were performed with SAS Enterprise statistical software version 7.12 (SAS Inc). Data analyses were performed from March 15, 2019, through September 23, 2019.

Results {#H1-3-ZOI190594}
=======

In 2016, 1 766 790 Medicare enrollees in the 20% sample were aged 21 to 64 years and received their initial Medicare entitlement because of disability. The mean (SD) age of this cohort was 52.2 (10.2) years; 866 914 (49.1%) were women, and 899 876 (50.9%) were men. This 14.9% (95% CI, 14.9%-15.0%) of all enrollees accounted for 80.8% (95% CI, 78.9%-82.7%) of opioid overdose deaths among all Medicare enrollees. The remaining analyses focus on opioid overdose deaths in this Medicare population younger than 65 years who qualified for disability. The opioid overdose mortality rate in this population increased from 57.4 per 100 000 (95% CI, 53.9-61.0 per 100 000) in 2012 to 77.6 per 100 000 (95% CI, 73.5-81.8 per 100 000) in 2016.

[Table 1](#zoi190594t1){ref-type="table"} shows the characteristics and conditions for Medicare enrollees aged 21 to 64 years with a disability entitlement and also for the subset who died because of opioid overdose. In general, those who died from opioid overdose were more likely than the study population to be younger (mean \[SD\] age, 49.7 \[9.9\] years vs 52.2 \[10.2\] years), male (773 \[56.4%\] vs 899 876 \[50.9%\]), white (1114 \[81.3%\] vs 1 170 832 \[66.3%\]), and eligible for Medicaid (796 \[58.1%\] vs 866 544 \[49.0%\]). A larger proportion of these individuals also had psychiatric diseases (depression, 436 \[56.8%\] vs 264 809 \[30.2%\]; anxiety, 487 \[63.4%\] vs 279 297 \[30.9%\]; and bipolar disorder, 273 \[35.6%\] vs 122 830 \[14.0%\]), substance use disorder (tobacco use disorder, 437 \[56.9%\] vs 207 378 \[23.7%\]; alcohol use disorder, 186 \[24.2%\] vs 58 582 \[6.7%\]; and drug use disorder, 432 \[56.3%\] vs 105 625 \[12.1%\]), and chronic pain (489 \[63.7%\] vs 271 913 \[31.1%\]). [Table 2](#zoi190594t2){ref-type="table"} presents the results of a stepwise logistic regression model estimating opioid overdose deaths in 2016 among Medicare enrollees younger than 65 years who qualified for disability. In the final models, we found that being male and white, having higher income, coverage with Medicare Part D, enrollment under disability entitlement less than 15 years, and living in metropolitan areas were associated with higher rates of opioid overdose death. Chronic conditions associated with a higher rate of opioid overdose death were associated with substance abuse, including opioid use disorder (adjusted odds ratio \[aOR\], 3.23; 95% CI, 2.56-4.06), drug use disorder (aOR, 1.86; 95% CI, 1.47-2.37), and tobacco use disorder (aOR, 1.77; 95% CI, 1.49-2.09); psychiatric diseases, including anxiety (aOR, 1.65; 95% CI, 1.37-1.97), bipolar disorder (aOR, 1.51; 95% CI, 1.28-1.79), and depression (aOR, 1.29; 95% CI, 1.09-1.53); and chronic pain (aOR, 1.86; 95% CI 1.57-2.21). Chronic kidney disease (aOR, 1.59; 95% CI, 1.32-1.91), pressure and chronic ulcers (aOR, 1.48; 95% CI, 1.11-1.96), and hepatitis (aOR, 1.68; 95% CI, 1.37-2.05) were also associated with a greater likelihood of opioid overdose death. The C-statistic for the model was 0.863.

###### Demographic Characteristics and Medical Conditions Associated With Opioid Overdose Deaths in Medicare Enrollees Aged 21 to 64 Years Qualified for Disability in 2016[^a^](#zoi190594t2n1){ref-type="table-fn"}

  Variable                                  Unadjusted Opioid Overdose Mortality   aOR (95% CI)[^b^](#zoi190594t2n2){ref-type="table-fn"}   
  ----------------------------------------- -------------------------------------- -------------------------------------------------------- ------------------
  Demographic characteristics                                                                                                               
  Sex                                                                                                                                       
  Male                                      413                                    91.5 (82.9-100.5)                                        1 \[Reference\]
  Female                                    353                                    84.1 (75.6-93.1)                                         0.76 (0.66-0.89)
  Race/ethnicity                                                                                                                            
  White                                     637                                    105.2 (97.2-113.5)                                       1 \[Reference\]
  Black                                     57                                     35.5 (26.9-45.3)                                         0.45 (0.34-0.59)
  Hispanic                                  39                                     55.2 (39.2-73.8)                                         0.61 (0.44-0.85)
  Other                                     33                                     95.8 (65.9-131.1)                                        1.07 (0.76-1.53)
  Years under disability insurance                                                                                                          
  ≤4                                        137                                    92.6 (77.8-108.8)                                        1.54 (1.21-1.95)
  5-8                                       317                                    111.9 (99.9-124.5)                                       1.64 (1.34-2.00)
  9-14                                      170                                    95.6 (81.8-110.5)                                        1.38 (1.10-1.73)
  ≥15                                       142                                    54.2 (45.6-63.5)                                         1 \[Reference\]
  Zip code income                                                                                                                           
  Quartile 1 (lowest)                       232                                    76.9 (67.3-87.1)                                         0.77 (0.62-0.95)
  Quartile 2                                208                                    84.7 (73.6-96.6)                                         0.74 (0.60-0.91)
  Quartile 3                                167                                    88.0 (75.2-101.9)                                        0.72 (0.58-0.90)
  Quartile 4 (highest)                      159                                    118.5 (100.8-137.6)                                      1 \[Reference\]
  Rural vs urban                                                                                                                            
  Metropolitan                              638                                    97.2 (89.8-104.9)                                        1 \[Reference\]
  Urban                                     113                                    58.9 (48.5-70.2)                                         0.61 (0.49-0.75)
  Rural                                     15                                     65.4 (36.6-102.4)                                        0.68 (0.40-1.15)
  Medicare Part D enrollment                                                                                                                
  Yes                                       683                                    97.8 (90.6-105.2)                                        1.34 (1.06-1.69)
  No                                        83                                     48.1 (38.3-59.0)                                         1 \[Reference\]
  Medical conditions                                                                                                                        
  Psychiatric diseases                                                                                                                      
  Depression                                                                                                                                
  No                                        331                                    54.5 (48.8-60.5)                                         1 \[Reference\]
  Yes                                       435                                    165.0 (149.8-180.8)                                      1.29 (1.09-1.53)
  Anxiety                                                                                                                                   
  No                                        281                                    46.7 (41.4-52.3)                                         1 \[Reference\]
  Yes                                       485                                    180.3 (164.6-196.7)                                      1.65 (1.37-1.97)
  Bipolar disorder                                                                                                                          
  No                                        493                                    65.8 (60.2-71.8)                                         1 \[Reference\]
  Yes                                       273                                    223.2 (197.5-250.5)                                      1.51 (1.28-1.79)
  Posttraumatic stress disorder                                                                                                             
  No                                        672                                    81.3 (75.2-87.5)                                         1 \[Reference\]
  Yes                                       94                                     213.0 (172.2-258.2)                                      0.73 (0.58-0.92)
  Substance abuse                                                                                                                           
  Tobacco use disorder                                                                                                                      
  No                                        329                                    49.5 (44.3-55.0)                                         1 \[Reference\]
  Yes                                       437                                    211.7 (192.3-232.0)                                      1.77 (1.49-2.09)
  Drug use disorder                                                                                                                         
  No                                        334                                    43.6 (39.1-48.4)                                         1 \[Reference\]
  Yes                                       432                                    410.8 (373.0-450.5)                                      1.86 (1.47-2.37)
  Opioid use diagnosis or procedure                                                                                                         
  No                                        416                                    50.9 (46.1-55.9)                                         1 \[Reference\]
  Yes                                       350                                    645.7 (579.8-715.1)                                      3.23 (2.56-4.06)
  Chronic pain                                                                                                                              
  Fibromyalgia, chronic pain, and fatigue                                                                                                   
  No                                        278                                    46.3 (41.0-51.9)                                         1 \[Reference\]
  Yes                                       488                                    180.3 (164.7-196.6)                                      1.86 (1.57-2.21)
  Other diagnoses                                                                                                                           
  Hypertension                                                                                                                              
  No                                        485                                    96.2 (87.9-105.0)                                        1 \[Reference\]
  Yes                                       281                                    76.5 (67.8-85.7)                                         0.68 (0.58-0.81)
  Hyperlipidemia                                                                                                                            
  No                                        630                                    105.7 (97.6-114.1)                                       1 \[Reference\]
  Yes                                       136                                    49.5 (41.5-58.1)                                         0.48 (0.39-0.58)
  Hepatitis                                                                                                                                 
  No                                        633                                    75.6 (69.8-81.6)                                         1 \[Reference\]
  Yes                                       133                                    393.2 (329.2-462.7)                                      1.68 (1.37-2.05)
  Chronic kidney disease                                                                                                                    
  No                                        576                                    80.5 (74.1-87.2)                                         1 \[Reference\]
  Yes                                       190                                    122.2 (105.4-140.2)                                      1.59 (1.32-1.91)
  Chronic obstructive pulmonary disease                                                                                                     
  No                                        633                                    83.4 (77.0-90.0)                                         1 \[Reference\]
  Yes                                       133                                    118.5 (99.2-139.4)                                       0.79 (0.64-0.97)
  Cancer                                                                                                                                    
  No                                        750                                    89.7 (83.4-96.2)                                         1 \[Reference\]
  Yes                                       16                                     46.3 (26.4-71.5)                                         0.49 (0.29-0.80)
  Peripheral vascular disease                                                                                                               
  No                                        722                                    89.6 (83.2-96.2)                                         1 \[Reference\]
  Yes                                       44                                     67.6 (49.1-89.0)                                         0.70 (0.50-0.97)
  Pressure and chronic ulcers                                                                                                               
  No                                        705                                    84.8 (78.6-91.1)                                         1 \[Reference\]
  Yes                                       61                                     154.8 (118.4-196.0)                                      1.48 (1.11-1.96)
  Anemia                                                                                                                                    
  No                                        623                                    87.1 (80.4-94.1)                                         1 \[Reference\]
  Yes                                       143                                    91.8 (77.3-107.4)                                        0.79 (0.65-0.97)
  Hypothyroidism                                                                                                                            
  No                                        709                                    92.0 (85.3-98.9)                                         1 \[Reference\]
  Yes                                       57                                     56.9 (43.1-72.6)                                         0.62 (0.47-0.82)
  Cataract                                                                                                                                  
  No                                        750                                    91.8 (85.4-98.5)                                         1 \[Reference\]
  Yes                                       16                                     29.3 (16.8-45.4)                                         0.44 (0.27-0.72)
  Deafness and hearing impairment                                                                                                           
  No                                        755                                    89.3 (83.1-95.8)                                         1 \[Reference\]
  Yes                                       11                                     42.8 (21.4-71.5)                                         0.54 (0.29-0.97)

Abbreviation: aOR, adjusted odds ratio.

Enrollees with completed data (n = 871 098) were included in the model. There were 4584 (0.5%) enrollees with missing data because of the linkage between their residential zip code and US Census data.

Odds ratios were calculated from the stepwise logistic regression model, with *P* = .05 to add and remove the predictor. The maximum rescaled *R*^2^ for the model is 0.137. *P*  \< .001 from Hosmer and Lemeshow goodness-of-fit test. In general, this test is sensitive to large sample size.

[Table 3](#zoi190594t3){ref-type="table"} shows the opioid overdose mortality rates for the 3 major categories of conditions: substance abuse, psychiatric diseases, and chronic pain. The logistic model including only these conditions with no demographic variables had a C-statistic of 0.82. Among the 37.5% (95% CI, 37.4%-37.7%) of beneficiaries younger than 65 years with Medicare disability entitlement who did not have any of the 3 categories of conditions, the opioid overdose mortality rate in 2016 was 15.5 per 100 000 (95% CI, 11.6-20.1 per 100 000). In contrast, the 11.1% (95% CI, 11.0%-11.2%) of beneficiaries who had all 3 categories of conditions had an opioid overdose mortality rate of 363.7 per 100 000 (95% CI, 326.7-402.6 per 100 000), which is 23.4 times higher than the rate for enrollees without any of the conditions and accounts for 45.8% of all opioid overdose deaths. The 8.1% (95% CI, 8.0%-8.2%) of beneficiaries with substance abuse plus psychiatric diseases without a pain diagnosis had an opioid overdose mortality rate of 187.5 per 100 000 (95% CI, 157.0-220.7 per 100 000), and the 9.3% (95% CI, 9.2%-9.4%) of beneficiaries with pain plus psychiatric diseases without a substance abuse diagnosis had an opioid overdose mortality of 84.6 per 100 000 (95% CI, 65.9-105.7 per 100 000) ([Table 3](#zoi190594t3){ref-type="table"}). Overall, 78.0% of all opioid overdose deaths occurred in the 32.0% of enrollees qualified for disability who had at least 2 major condition categories.

###### Proportion of Enrollees and the Rate of Opioid Overdose Deaths per 100 000 in 2016 Among Medicare Beneficiaries Aged 21 to 64 Years Who Qualified for Disability With 3 Major Condition Categories: Psychiatric Diseases, Substance Abuse, and Chronic Pain

  Major Condition Category   Medicare Enrollees With Disability Entitlement   Opioid Overdose Mortality                                      
  -------------------------- ------------------------------------------------ --------------------------- --------- ------------------ ----- ---------------------
  Yes                        Yes                                              Yes                         96 790    11.1 (11.0-11.2)   352   363.7 (326.7-402.6)
  Yes                        Yes                                              No                          70 940    8.1 (8.0-8.2)      133   187.5 (157.0-220.7)
  Yes                        No                                               Yes                         81 527    9.3 (9.2-9.4)      69    84.6 (65.9-105.7)
  No                         Yes                                              Yes                         31 383    3.6 (3.5-3.6)      45    143.4 (104.6-188.2)
  Yes                        No                                               No                          153 257   17.5 (17.4-17.6)   55    35.9 (27.0-46.0)
  No                         Yes                                              No                          51 000    5.8 (5.8-5.9)      40    78.4 (56.0-104.5)
  No                         No                                               Yes                         62 213    7.1 (7.0-7.2)      23    37.0 (23.4-53.5)
  No                         No                                               No                          328 572   37.5 (37.4-37.7)   51    15.5 (11.6-20.1)

Psychiatric disease included anxiety, depression, or bipolar disorder.

Substance abuse included tobacco, drug, or opioid use disorder.

To explore the robustness of study results from 2016, we repeated analyses with person-year data from 2012 to 2015. Seven additional conditions (intellectual disability, multiple sclerosis, spina bifida, blindness, traumatic brain injury, acute myocardial infarction, and glaucoma) excluded in the 2016 analysis because of CMS cell size suppression were added in the multivariable analyses because they were associated with 11 or more opioid overdose deaths in the 2012 to 2015 data. The final stepwise logistic regression model from this sensitivity analyses had C-statistics of 0.857 compared with 0.863 in the main analyses. Aside from pressure and chronic ulcers, positive associations with opioid overdose deaths for all other conditions from our main analyses persisted. Three additional conditions---ischemic heart disease, arthritis, and alcohol use disorder---were found to be positively associated with outcomes in the final model of sensitivity analyses.

We compared our results with the CDC report on opioid overdose deaths,^[@zoi190594r10]^ which reported an age-adjusted rate of opioid overdose deaths in the US population in 2016 of 13.3 per 100 000. Assuming that the rate at age 15 to 24 years was the same as that for age 20 to 24 years, the age-adjusted rate was 20.8 per 100 000 for those aged 20 to 64 years in the United States. In contrast, the age-adjusted rate was 99.9 per 100 000 in our study of Medicare enrollees aged 21 to 64 years who qualified for disability, which is at least 4.8 times higher than that of the general US population in 2016.^[@zoi190594r10]^ On the basis of our findings of 1371 opioid overdose deaths in this population from the 20% Medicare sample, we estimated that approximately 16% of the 42 249 opioid overdose deaths in 2016 reported by the CDC occurred in this population.

Discussion {#H1-4-ZOI190594}
==========

The finding of increased opioid overdose deaths among adults who qualified for Medicare because of disability is consistent with the CDC report of increased mortality across multiple demographic groups.^[@zoi190594r10]^ The mortality rate in our study is 4.8 times higher than that of the general US population in 2016.^[@zoi190594r10]^ The 37.5% of the study population with no diagnosis of psychiatric diseases, chronic pain, or substance abuse had an age-adjusted rate of opioid overdose death of 15.5 per 100 000, which is lower than that of the US population.^[@zoi190594r10]^ The rate of overdose death greatly increased for patients with any of these 3 conditions, with the highest rate among those with all 3 condition categories.

Previous studies^[@zoi190594r3],[@zoi190594r11]^ have reported high rates of prescription opioid use among Medicare adults who qualified for disability. In addition to contextual characteristics, such as county income, income disparity, and unemployment rates,^[@zoi190594r12]^ other risk factors associated with higher opioid use in this population were mental illness and chronic pain.^[@zoi190594r13],[@zoi190594r14]^ The proportion of adult Medicare enrollees with disability entitlement who had a chronic pain diagnosis in our study population (31.1%) was consistent with that of a previous report.^[@zoi190594r15]^ Our finding of an association of Medicare Part D enrollment with opioid overdose death is also consistent with the results from a Veterans Affairs study,^[@zoi190594r16]^ presumably attributable to increased access to prescription opioids.

In the multivariable model, dual-eligible enrollment with Medicaid was not associated with opioid overdose death. We found an unexpected positive association between opioid overdose death and residence in the higher-income zip codes. There is a negative association between income and opioid prescriptions at the county level.^[@zoi190594r17],[@zoi190594r18]^ At the individual level, a study^[@zoi190594r19]^ based on data from the National Survey on Drug Use and Health also showed that those with lower income were more likely to misuse opioids and had higher rates of opioid use disorder than the general US population. Another study^[@zoi190594r20]^ of the Medicare population showed that enrollees residing in higher-income zip codes had lower rates of long-term opioid prescriptions. It is unclear why higher rates of opioid overdose death were associated with higher income in our study, despite the previously reported lower rate of prescription opioid use in this population. Our findings of higher rates of opioid overdose death in metropolitan areas add additional evidence to the conflict surrounding this topic.^[@zoi190594r21]^ Future studies assessing the association of overdose mortality with income and urban or rural residence stratified by opioid type may give more insight to our unexpected findings.

Subgroups of adults enrolled in Medicare because of disability with different risk profiles for opioid overdose death might benefit from different interventions. For example, the subset of beneficiaries with the lowest rate of opioid overdose deaths likely represents a population for whom prescription opioids can be safely offered by their physicians as part of comprehensive pain management if the clinical condition warrants opioid analgesics. For those at the highest risk of opioid overdose deaths, examples of targeted interventions include case management developed for and tailored to a high-risk population and Medicare-mandated requirement for comanagement by pain, addiction, and mental health specialists in treating pain in these populations. These interventions would have the biggest impact on the subgroups with at least 2 major condition categories that comprised 32.0% of all enrollees who qualified for disability but accounted for 78.0% of all opioid overdose deaths in this population. Patient-informed and evidence-supported comanagement strategies and targeted interventions (including enhanced access to substance use disorder treatment) have the potential to reduce opioid overdose deaths in this high-risk population while ensuring effective pain management.

Limitations {#H2-2-ZOI190594}
-----------

This study has limitations. First, the quality and accuracy of death certificate data associated with overdose varies across states.^[@zoi190594r10],[@zoi190594r22]^ In addition, we could not distinguish from our data between deaths deemed accidental, suicide, or homicide or between the deaths that occurred in the inpatient or outpatient setting. Second, we restricted the analyses of associations with medical conditions to enrollees with 2 years of continuous enrollment with fee-for-service coverage. Our results may not be generalizable to health maintenance organization populations. Third, the validity of medical conditions derived from claims data varies. Fourth, we provided descriptive results to show the differences in rates of opioid overdose death across subgroups. We did not conduct analyses to incorporate competing causes of death. Fifth, we did not analyze the association of drug interactions or contaminated street drugs with opioid overdose mortality. Future studies examining the use of pain medications, psychiatric medications, and the 2 in combination is important for understanding why the opioid overdose death rate is much higher in this population. Sixth, we used stepwise regression to find the most important patient characteristics and health conditions associated with opioid overdose mortality in a parsimonious model, with the understanding of the concerns for the bias in parameter and SE estimation.^[@zoi190594r23]^ However, our findings in isolating the 3 major condition categories were robust in our analyses of 2012 to 2015 data.

Conclusions {#H1-5-ZOI190594}
===========

Despite the high rates of opioid use in the Medicare population entitled for disability, research^[@zoi190594r24],[@zoi190594r25]^ shows lower utilization of opioid treatment programs. This population is heterogeneous, with physical and cognitive disorders present at birth along with conditions acquired later in life. The conditions most significantly associated with opioid overdose deaths in our analyses most commonly occur or are recognized in adolescence or later. There is currently a major federal effort to increase access to opioid use disorder treatment programs and to promote knowledge and use of opioid antagonists in cases of suspected overdose. Such programs work best with accurate targeting of populations at high risk. Our findings suggest that straightforward analyses of Medicare data can identify subgroups of Medicare enrollees with the highest rates of death from opioid overdose. Further studies are needed to understand the heterogeneity of medical and psychiatric conditions associated with opioid use, misuse, addiction, and overdose in this population. Such understanding is key to developing specific, data-driven interventions (eg, programs to manage co-occurring substance use disorder and requirement for comanagement by pain, mental health, and addiction specialists) targeted for each subgroup of high-risk populations.
